Efavirenz-associated Stevens-Johnson syndrome [2]

Infection

Volumn 32, Issue 5, 2004, Pages 306-307

  Colebunders, R ^a   Vanwolleghem, T ^b   Meurrens, P ^b   Moerman, F ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE;

ADULT; CASE REPORT; CONJUNCTIVITIS; DRUG INDUCED DISEASE; ERYTHEMA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MUCOSA INFLAMMATION; PNEUMOCYSTIS PNEUMONIA; STEVENS JOHNSON SYNDROME;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DAPSONE; FEMALE; HUMANS; OXAZINES; STEVENS-JOHNSON SYNDROME;

EID: 4844226893     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-004-4034-8     Document Type: Letter

References (7)

1. Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM: Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol 2003; 3: 1-9.
2. Zangerle R: Cutaneous drug reactions in HIV-infected patients. Dermatol Ther 1999; 12: 115-130.
3. Carr A, Swanson C, Penny R, Cooper DA: Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993; 167: 180-185.
4. Pertel P, Hischtick R: Adverse reactions to Dapsone in persons infected with human immunodeficiency virus. Clin Infect Dis 1994; 18: 630-632.
5. Nunn P, Kibuga D, Gathua S, Brindle R, Imalingat A, Wasunna K, Lucas S, Gilks C, Omwega M, Were J, McAdam K: Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropos-itive patients treated for tuberculosis. Lancet 1991; 337: 627-630.
6. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; EuroSCAR Study Group: Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001; 15: 1843-1848.
7. Dodi F, Alessandrini A, Camera M, Gaffuri L, Morandi N, Pagano G: Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports. AIDS 2002; 16: 1197-1198.